Holen Sie sich die Stockscreener-App
2.97
1.37%
0.04
Finanzdaten der Tscan Therapeutics Inc-Aktie (TCRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
92.15%
0.566
|
7.211 | 3.887 | 3.148 | 6.803 |
Operating Expenses
|
11.80%
31.94
|
28.57 | 28.64 | 27.76 | 29.55 |
| Interest Income/Expense |
12.56%
0.959
|
0.852 | 0.982 | 0.969 | 0.956 |
| Benefits Costs and Expenses |
14.48%
30.71
|
26.82 | - | - | 29.37 |
| Costs And Expenses |
14.48%
30.71
|
26.82 | 28.64 | 27.76 | 29.37 |
| Operating Income/Loss |
46.90%
-31.37
|
-21.36 | -24.75 | -24.61 | -22.74 |
| Income/Loss From Continuing Operations Before Tax |
53.68%
-30.14
|
-19.61 | 3.887 | 3.148 | -22.56 |
| Income/Loss From Continuing Operations After Tax |
53.68%
-30.14
|
-19.61 | -23.00 | -24.05 | -22.56 |
|
Net Income/Loss
|
53.68%
-30.14
|
-19.61 | -23.00 | -24.05 | -22.56 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
859.45%
94.88
|
9.8886 | 94.83 | 47.21 | 24.23 |
| Diluted Average Shares |
859.45%
94.88
|
9.8886 | 94.83 | 47.21 | 24.23 |
| Basic Earnings Per Share |
190.91%
-0.32
|
-0.11 | -0.24 | -0.51 | -0.93 |
| Diluted Earnings Per Share |
190.91%
-0.32
|
-0.11 | -0.24 | -0.51 | -0.93 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):